Hyderabad-based pharma penny stock under Rs 50: Company Announced New 12,000 MTPA MCC Facility at Dahej SEZ

On Thursday share price of Sigachi Industries Limited was trading in negative territory at Rs 32.10 per share, down by 7.15 per cent.

Sigachi Industries Limited, a prominent Indian manufacturer of pharmaceutical excipients, APIs, and specialty ingredients, announced on August 7, 2025, the commencement of civil works for its next significant capacity expansion project. This strategic initiative involves the development of an advanced 12,000 MTPA (Metric Tonnes Per Annum) Microcrystalline Cellulose (MCC) facility at its existing Dahej SEZ unit located in Gujarat. This move underscores Sigachi’s long-term commitment to operational resilience, a safety-first design philosophy, and its ongoing leadership in the global excipient industry.

The company highlighted that this expansion is a testament to its determination to strengthen its operations following a recent incident at its Pashamylaram unit, even as the investigation committee continues its work. Sigachi aims to emerge stronger by implementing smarter systems and globally benchmarked safety features. The new 12,000 MTPA MCC capacity at Dahej SEZ is projected to become operational within 9 months. A new Spray Dryer system, crucial for the MCC manufacturing process, is being procured in consultation with renowned equipment manufacturers and safety experts to ensure the highest standards of safety and excellence. 

Once this new facility is operational, Sigachi’s total installed MCC capacity will increase to 30,000 MTPA, solidifying its position as the largest manufacturer of MCC in India and among the top globally. This expansion, combined with increased production at its Jhagadia and existing Dahej SEZ facilities, is also intended to reinforce business continuity, ensuring uninterrupted supply to its valued global clientele.

Also Read: Stock Market Update 

Also Read: Penny Stock Under Re 1 Hits Back-to-Back Upper Circuits: Stock Price Hit 5% Upper Circuit for 4th Day After OTS Deal with Central Bank of India

About the Company

Sigachi Industries Limited, a publicly traded pharmaceutical company listed on NSE and BSE, is a global leader in providing high-quality excipients, vitamin-mineral nutrient blends, APIs, and O&M services. With over 35 years of industry expertise, Sigachi has built a strong reputation as a trusted partner for pharmaceutical and nutraceutical companies worldwide. They specialise in innovative solutions for food stability, fortification, and nutrition, offering tailored blends of vitamins, minerals, and other ingredients to meet the evolving needs of consumers. By utilising advanced technologies like blending, encapsulation, and spray drying, Sigachi empowers food manufacturers to create products with superior taste, quality, and nutritional value, contributing to a healthier and happier world.

The company announced positive Quarterly Results (Q4FY25) and annual results (FY25). According to quarterly results, revenue increased by 23 per cent to Rs 128.21 crore, EBITDA increased by 30 per cent to Rs 30.75 crore and net profit increased by 7 per cent to Rs 16.17 crore in Q4FY25 compared to Q4FY24. In its annual results, revenue increased by 22 per cent to Rs 488.24 crore, EBITDA increased by 36 per cent to Rs 120.50 crore and consolidated PAT increased by 22 per cent to Rs 70.46 crore in FY25 compared to FY24.

Disclaimer: The article is for informational purposes only and not investment advice.